Co-Diagnostics Operating Expenses Growth & History (CODX)
Co-Diagnostics's operating expenses was $50.6M for fiscal 2025.
View full Co-Diagnostics company overviewCo-Diagnostics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $50.6M | $7.6M | +17.60% |
| 2024 | 2024-12-31 | $43.0M | −$2.3M | −5.15% |
| 2023 | 2023-12-31 | $45.3M | −$10.4M | −18.64% |
| 2022 | 2022-12-31 | $55.7M | $15.5M | +38.44% |
| 2021 | 2021-12-31 | $40.2M | $24.0M | +147.40% |
| 2020 | 2020-12-31 | $16.3M | $10.3M | +171.30% |
| 2019 | 2019-12-31 | $6.0M | −$152,052 | −2.47% |
| 2018 | 2018-12-31 | $6.1M | $1.6M | +34.49% |
| 2017 | 2017-12-31 | $4.6M | $2.9M | +170.82% |
| 2016 | 2016-12-31 | $1.7M | — | — |
Co-Diagnostics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.3M | −$1.9M | −22.80% |
| Q1 2026 | 2026-03-31 | $9.2M | $579,954 | +6.76% |
| Q4 2025 | 2025-12-31 | $26.7M | $14.9M | +125.94% |
| Q3 2025 | 2025-09-30 | $7.1M | −$3.4M | −32.57% |
| Q2 2025 | 2025-06-30 | $8.2M | −$1.9M | −19.12% |
| Q1 2025 | 2025-03-31 | $8.6M | −$1.9M | −18.22% |
| Q4 2024 | 2024-12-31 | $11.8M | −$611,249 | −4.92% |
| Q3 2024 | 2024-09-30 | $10.6M | −$558,602 | −5.02% |
| Q2 2024 | 2024-06-30 | $10.1M | −$1.6M | −13.71% |
| Q1 2024 | 2024-03-31 | $10.5M | $442,370 | +4.40% |
| Q4 2023 | 2023-12-31 | $12.4M | −$14.6M | −54.04% |
| Q3 2023 | 2023-09-30 | $11.1M | $275,142 | +2.53% |
| Q2 2023 | 2023-06-30 | $11.7M | $3.5M | +42.14% |
| Q1 2023 | 2023-03-31 | $10.1M | $457,432 | +4.77% |
| Q4 2022 | 2022-12-31 | $27.0M | $19.4M | +255.08% |
| Q3 2022 | 2022-09-30 | $10.9M | −$2.3M | −17.46% |
| Q2 2022 | 2022-06-30 | $8.3M | −$4.8M | −36.81% |
| Q1 2022 | 2022-03-31 | $9.6M | $3.2M | +49.49% |
| Q4 2021 | 2021-12-31 | $7.6M | $802,734 | +11.80% |
| Q3 2021 | 2021-09-30 | $13.2M | $9.2M | +232.38% |
| Q2 2021 | 2021-06-30 | $13.1M | $9.7M | +289.15% |
| Q1 2021 | 2021-03-31 | $6.4M | $4.3M | +198.65% |
| Q4 2020 | 2020-12-31 | $6.8M | $5.1M | +305.15% |
| Q3 2020 | 2020-09-30 | $4.0M | $2.3M | +136.92% |
| Q2 2020 | 2020-06-30 | $3.4M | $2.0M | +141.74% |
| Q1 2020 | 2020-03-31 | $2.1M | $891,297 | +70.88% |
| Q4 2019 | 2019-12-31 | $1.7M | −$145,523 | −7.98% |
| Q3 2019 | 2019-09-30 | $1.7M | −$2,309 | −0.14% |
| Q2 2019 | 2019-06-30 | $1.4M | $25,467 | +1.87% |
| Q1 2019 | 2019-03-31 | $1.3M | −$29,687 | −2.31% |
| Q4 2018 | 2018-12-31 | $1.8M | $328,394 | +21.95% |
| Q3 2018 | 2018-09-30 | $1.7M | −$134,193 | −7.42% |
| Q2 2018 | 2018-06-30 | $1.4M | $659,946 | +93.86% |
| Q1 2018 | 2018-03-31 | $1.3M | $722,762 | +128.07% |
| Q4 2017 | 2017-12-31 | $1.5M | — | — |
| Q3 2017 | 2017-09-30 | $1.8M | $1.4M | +360.72% |
| Q2 2017 | 2017-06-30 | $703,116 | $312,825 | +80.15% |
| Q1 2017 | 2017-03-31 | $564,365 | — | — |
| Q3 2016 | 2016-09-30 | $392,352 | — | — |
| Q2 2016 | 2016-06-30 | $390,291 | — | — |
Co-Diagnostics operating expenses trends
Over the last five fiscal years, Co-Diagnostics's operating expenses increased from $16.3M to $50.6M, a change of $34.3M. The latest reported quarter, Q2 2026, shows $6.3M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Co-Diagnostics source filings ↗